Pipeline
The Science
About us
Investors

Hit enter to search or ESC to close

AGM Presentation

November 12, 2015August 16, 2022 Alterity Therapeutics

2015_11_13 Prana AGM Presentation 2

2015

Post navigation

Prana AGM Webcast Details

Prana Maintains NASDAQ Listing

Related Posts

Alterity Therapeutics presents data on ATH434 to the American Academy of Neurology

May 21, 2020August 16, 2022

Alterity Therapeutics to Participate in the Sachs Associates 6^th Annual Neuroscience Innovation Forum

January 3, 2023May 23, 2023

Prana Alzheimer’s disease data features at world leading conference

July 27, 2016August 16, 2022

Recent Posts

Alterity to Participate in a Fireside Chat at the 2024 Maxim Healthcare Virtual Summit on 17 October 2024
Alterity Therapeutics Announces Presentation of New Data Describing Neuroprotection of ATH434 at Neuroscience Meeting
Alterity Therapeutics Raises Profile with Multiple Data Presentations at the International Congress of Parkinson’s Disease and Movement Disorders®
XBRL 30 June 2024 filed with the SEC
Alterity Therapeutics Appoints Abby Macnish Niven as Chief Financial Officer

Recent Comments

Archives

Archives

Categories

ASX Announcements
Chairman's Address
Investor Announcement

Tags

2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023

About us

We exist to create an alternate future for people living with neurodegenerative diseases. An alternate, healthier life. We’re here to disrupt the trajectory the world has come to accept for people with these diseases.
Improving lives.

LinkedIn
Facebook
X

Pipeline
The Science
About us
Investors
News

Careers
Privacy Policy

Copyright © Alterity Therapeutics. ABN 37 080 699 065